MedDataX Logo

Observational Non-Interventional Study With Spiriva Respimat in COPD Patients

NCT ID: NCT00699699

Last Updated: 2014-04-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1280 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational non-interventional study is designed to demonstrate the improvement of physical function in COPD patients on treatment with Spiriva Respimat and allows adverse events to be recorded and evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

NCT02173769

Pulmonary Disease, Chronic Obstructive
COMPLETED

Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice

NCT02675517

Pulmonary Disease, Chronic Obstructive
COMPLETED

Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)

NCT02720757

Pulmonary Disease, Chronic Obstructive
TERMINATED

Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)

NCT03165045

Pulmonary Disease, Chronic Obstructive
COMPLETED

An Exploratory, Observational, Non-interventional, Open Label, Remote Pilot Study to Assess Adherence in COPD Subjects

NCT03745547

Moderate Chronic Obstructive Pulmonary Disease Severe Chronic Obstructive Pulmonary Disease
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

COPD patients who require treatment with longacting anticholinergic

Exclusion Criteria

Patients cannot be recruited if any of the general or specific contraindications listed in the Patient information leaflet or the Summary of Product Characteristics applies. Spiriva® Respimat® is contraindicated in patients with hypersensitivity to tiotropium bromide, atropine or its derivatives, e.g. ipratropium or oxitropium or to any of the excipients.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site

Aachen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Amberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Auerbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Backnang, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bad Doberan, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bad Kötzing, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bad Lippspringe, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bad Nauheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bad Reichenhall, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Baden-Baden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Bergisch Gladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Bergisch Gladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 5

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 6

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 7

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 8

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bochum, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Bottrop, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Braunschweig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Braunschweig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Braunschweig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Bremerhaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Bremerhaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Burg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Castrop-Rauxel, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Celle, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Cottbus, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Detmold, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Dillenburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Donauwörth, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Dormagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Dorsten, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Dortmund, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Duisburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Düren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Emden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Emden, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Erbach im Odenwald, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Erfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Esslingen am Neckar, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Euskirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Flensbrug, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Flensburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Frankenthal, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Fürstenfeldbruck, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Fürstenwalde, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Fürth, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Geilenkirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Giessen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Giessen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Grimma, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Gütersloh, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Gütersloh, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Hainburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 5

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 6

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Hamm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Heilbronn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Heilbronn, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Herne, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Hildburghausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Hilden, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Hoyerswerda, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Ibbenbueren, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Karlsruhe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Kiel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Kiel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Konstanz, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Königs Wusterhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Kyritz, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Leipzig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Leverkusen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Leverkusen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Limbach-Oberfrohna, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Lüdenscheid, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Lüneburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Magdeburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Magdeburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Magdeburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Mannheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Markkleeberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Menden, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Moers, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Mönchengladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Mühlheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 5

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Nauen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Norderstedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Nordhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Nordhorn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Oberhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Oberhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Oberursel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Offenbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Offenbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Offenburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Olpe, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Oranienburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Osnabrück, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Peine, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Pforzheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Rastatt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Ratingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Ratingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Recklinghausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Remscheid, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Rostock, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Roth, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Rottach-Egern, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Rudolstadt, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Rüsselsheim am Main, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Saarlouis, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Saint Ingbert, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Salzgitter, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Schleswig, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Schmölln, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Schwandorf in Bayern, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Sebnitz, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Siegen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Singen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Solingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Solingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Solingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Solingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Stadthagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Steinhagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Strausberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Stremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Stuttgart, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Tauberbischofsheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Tübingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Ulm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Ulm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Ulm, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Velbert, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Waren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Wiesbaden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Wiesbaden, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Wiesloch, , Germany

Site Status

Boehringer Ingelheim Investigational Site 1

Wilhelmshaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Wilhelmshaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Witten, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Wittstock, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Wolfsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site

Zirndorf, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

205.426

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00259909 COMPLETED
Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
NCT02999685 COMPLETED NA
Optimizing Maintenance Therapy in COPD Patients
NCT04532853 COMPLETED
Exercise Capacity in COPD
NCT03889964 UNKNOWN
A Controlled Study of Community-based Exercise Training in Patients With Moderate COPD
NCT01985529 COMPLETED NA
Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test
NCT01644734 COMPLETED PHASE4
Community-Based Maintenance Exercise Program for COPD
NCT01942499 COMPLETED NA
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
NCT05259280 COMPLETED NA
Self-management Digital Intervention to Promote Physical Activity in People Living With COPD
NCT07262229 NOT_YET_RECRUITING NA
Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
NCT05492149 COMPLETED
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
NCT04257630 COMPLETED
Spirometry in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00965029 UNKNOWN
Interfaces of Non-invasive Ventilation on Performance in Patients With Chronic Obstructive Pulmonary Disease
NCT02796599 COMPLETED NA
Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI
NCT02936817 COMPLETED PHASE4
Home-based Exercise Training for COPD Patients
NCT03461887 COMPLETED NA
Assessing the Utility of Peak Inspiratory Flow as a Predictor for COPD Exacerbations
NCT04360226 COMPLETED
NIV-Training in Hypercapnic COPD Patients
NCT03803358 COMPLETED NA
Home Pulmonary Rehabilitation for COPD
NCT03480386 COMPLETED NA
Efficacy of Telemetry-assisted Care in Home Home Vented COPD
NCT05287555 COMPLETED NA
Promoting Activity After COPD Exacerbations, Aim 2
NCT03793192 TERMINATED NA
Acute Effects of Supramaximal High-Intensity Interval Training in People With COPD
NCT05874999 COMPLETED NA
Comprehensive Self-management Support for COPD Patients
NCT04533412 COMPLETED NA
CO2-Patterns During Hyperoxia and Physical Exercise in COPD
NCT04955561 UNKNOWN NA
Changes in Heart Rate Variability And Heart Rate/Activity Slope After Hospitalization for Acute Exacerbations of COPD
NCT05290831 UNKNOWN NA
Enabling Independent Living by Expanding Access to Home-Based Pulmonary Rehabilitation
NCT04479969 COMPLETED NA